Mural Oncology plc (MURA)
2025-06-30 | ||||
|---|---|---|---|---|
| Unrealized (loss) gain on marketable securities | -1 | |||
| Other comprehensive (loss) gain | -1 | |||
| Other income | 860 | |||
| Restructuring and impairment | 17,486 | |||
| Research and development | 23,277 | |||
| General and administrative | 8,079 | |||
| Total operating expenses | 48,842 | |||
| Operating loss | -48,842 | |||
| Net loss | -47,982 | |||
| Comprehensive loss | -47,983 | |||
| Earnings per share, basic | -2.78 | |||
| Earnings per share, diluted | -2.78 | |||
| Weighted average number of shares outstanding, basic | 17,271,518 | |||
| Weighted average number of shares outstanding, diluted | 17,271,518 | |||